Sacituzumab Tirumotecan in EGFR-TKI–Resistant, EGFR-Mutated Advanced NSCLC
Original Article
W. Fang, L. Wu, X. Meng, Y. Yao, W. Zuo, W. Yao, Y. Xie, Y. Zhang, J. Cui, Y. Zhang, X. Li, W. Zhuang, J. Fang, Q. Wang, W. Jiang, K. Li, Y. Bai, Y. Luo, F. Ma, Y. Yu, W. Zheng, Z. Liu, B. Yang, R. Ma, Y. Fang, R. Yang, L. Jiang, J. Hu, J. Yang, Y. Diao, X. Jin, J. Ge, Y. Yang, and L. Zhang
N Engl J Med 2026;394:13-26
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
12/31/2025
Course expires:
01/01/2028
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Please sign in or create an account to take the course.

Facebook
X
LinkedIn
Forward